nodes	percent_of_prediction	percent_of_DWPC	metapath
Alclometasone—CYP3A4—Topotecan—lung cancer	0.112	0.142	CbGbCtD
Alclometasone—CYP3A4—Gefitinib—lung cancer	0.103	0.13	CbGbCtD
Alclometasone—CYP3A4—Teniposide—lung cancer	0.0998	0.126	CbGbCtD
Alclometasone—CYP3A4—Vinorelbine—lung cancer	0.0793	0.1	CbGbCtD
Alclometasone—CYP3A4—Crizotinib—lung cancer	0.0631	0.0796	CbGbCtD
Alclometasone—CYP3A4—Erlotinib—lung cancer	0.0608	0.0768	CbGbCtD
Alclometasone—CYP3A4—Paclitaxel—lung cancer	0.0557	0.0703	CbGbCtD
Alclometasone—CYP3A4—Irinotecan—lung cancer	0.0549	0.0694	CbGbCtD
Alclometasone—CYP3A4—Vinblastine—lung cancer	0.0488	0.0617	CbGbCtD
Alclometasone—CYP3A4—Etoposide—lung cancer	0.044	0.0556	CbGbCtD
Alclometasone—CYP3A4—Docetaxel—lung cancer	0.0403	0.0508	CbGbCtD
Alclometasone—CYP3A4—Doxorubicin—lung cancer	0.03	0.0379	CbGbCtD
Alclometasone—Dermatitis acneiform—Erlotinib—lung cancer	0.0101	0.112	CcSEcCtD
Alclometasone—Folliculitis—Erlotinib—lung cancer	0.00551	0.061	CcSEcCtD
Alclometasone—Secondary infection—Doxorubicin—lung cancer	0.00362	0.0401	CcSEcCtD
Alclometasone—Folliculitis—Paclitaxel—lung cancer	0.0032	0.0354	CcSEcCtD
Alclometasone—Leukoderma—Methotrexate—lung cancer	0.00289	0.032	CcSEcCtD
Alclometasone—Hydrocortisone—ANXA1—lung cancer	0.00261	0.195	CrCbGaD
Alclometasone—Erythema—Pemetrexed—lung cancer	0.00255	0.0282	CcSEcCtD
Alclometasone—Leukoderma—Doxorubicin—lung cancer	0.0025	0.0277	CcSEcCtD
Alclometasone—Infection—Crizotinib—lung cancer	0.00226	0.025	CcSEcCtD
Alclometasone—Infection—Pemetrexed—lung cancer	0.00207	0.0229	CcSEcCtD
Alclometasone—Infection—Gefitinib—lung cancer	0.00205	0.0227	CcSEcCtD
Alclometasone—Folliculitis—Methotrexate—lung cancer	0.00196	0.0217	CcSEcCtD
Alclometasone—Dexamethasone—ANXA1—lung cancer	0.00195	0.145	CrCbGaD
Alclometasone—NR3C1—Nuclear Receptors—RARB—lung cancer	0.00177	0.0169	CbGpPWpGaD
Alclometasone—Folliculitis—Doxorubicin—lung cancer	0.00169	0.0188	CcSEcCtD
Alclometasone—NR3C1—Endoderm Differentiation—NKX2-1—lung cancer	0.00168	0.0161	CbGpPWpGaD
Alclometasone—Infection—Teniposide—lung cancer	0.00167	0.0185	CcSEcCtD
Alclometasone—Erythema—Erlotinib—lung cancer	0.00151	0.0167	CcSEcCtD
Alclometasone—Pruritus—Pemetrexed—lung cancer	0.00147	0.0163	CcSEcCtD
Alclometasone—Pruritus—Gefitinib—lung cancer	0.00146	0.0162	CcSEcCtD
Alclometasone—Rash—Crizotinib—lung cancer	0.00143	0.0159	CcSEcCtD
Alclometasone—Dermatitis—Crizotinib—lung cancer	0.00143	0.0159	CcSEcCtD
Alclometasone—NR3C1—Endoderm Differentiation—NODAL—lung cancer	0.00143	0.0137	CbGpPWpGaD
Alclometasone—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.00141	0.0135	CbGpPWpGaD
Alclometasone—NR3C1—Nuclear Receptor transcription pathway—RARB—lung cancer	0.0014	0.0134	CbGpPWpGaD
Alclometasone—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.00134	0.0128	CbGpPWpGaD
Alclometasone—Rash—Pemetrexed—lung cancer	0.00131	0.0145	CcSEcCtD
Alclometasone—Dermatitis—Pemetrexed—lung cancer	0.00131	0.0145	CcSEcCtD
Alclometasone—Erythema—Vinorelbine—lung cancer	0.00131	0.0145	CcSEcCtD
Alclometasone—Rash—Gefitinib—lung cancer	0.0013	0.0144	CcSEcCtD
Alclometasone—Dermatitis—Gefitinib—lung cancer	0.0013	0.0144	CcSEcCtD
Alclometasone—Infection—Topotecan—lung cancer	0.00124	0.0137	CcSEcCtD
Alclometasone—Infection—Erlotinib—lung cancer	0.00123	0.0136	CcSEcCtD
Alclometasone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.00122	0.0117	CbGpPWpGaD
Alclometasone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.00122	0.0117	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—lung cancer	0.0012	0.0115	CbGpPWpGaD
Alclometasone—Pruritus—Teniposide—lung cancer	0.00119	0.0132	CcSEcCtD
Alclometasone—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.00118	0.0113	CbGpPWpGaD
Alclometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—lung cancer	0.00116	0.0111	CbGpPWpGaD
Alclometasone—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.00116	0.0111	CbGpPWpGaD
Alclometasone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.00113	0.0109	CbGpPWpGaD
Alclometasone—Clobetasol propionate—CYP1A1—lung cancer	0.00112	0.0835	CrCbGaD
Alclometasone—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.00109	0.0105	CbGpPWpGaD
Alclometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—lung cancer	0.00109	0.0105	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—SOX2—lung cancer	0.00108	0.0104	CbGpPWpGaD
Alclometasone—Rash—Teniposide—lung cancer	0.00106	0.0118	CcSEcCtD
Alclometasone—Dermatitis—Teniposide—lung cancer	0.00106	0.0117	CcSEcCtD
Alclometasone—Infection—Vinorelbine—lung cancer	0.00106	0.0117	CcSEcCtD
Alclometasone—NR3C1—AP-1 transcription factor network—NPPA—lung cancer	0.00106	0.0101	CbGpPWpGaD
Alclometasone—Dermatitis contact—Doxorubicin—lung cancer	0.00105	0.0116	CcSEcCtD
Alclometasone—Erythema—Gemcitabine—lung cancer	0.00105	0.0116	CcSEcCtD
Alclometasone—Prednisolone—CYP2A6—lung cancer	0.00105	0.0783	CrCbGaD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—lung cancer	0.00104	0.00994	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—ATF3—lung cancer	0.001	0.00959	CbGpPWpGaD
Alclometasone—Erythema—Cisplatin—lung cancer	0.00098	0.0108	CcSEcCtD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000979	0.00939	CbGpPWpGaD
Alclometasone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000947	0.00909	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—PTHLH—lung cancer	0.000919	0.00882	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000916	0.00879	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—SFN—lung cancer	0.000901	0.00865	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—lung cancer	0.00089	0.00854	CbGpPWpGaD
Alclometasone—Pruritus—Topotecan—lung cancer	0.000883	0.00977	CcSEcCtD
Alclometasone—Erythema—Paclitaxel—lung cancer	0.00088	0.00974	CcSEcCtD
Alclometasone—Infection—Irinotecan—lung cancer	0.000875	0.00968	CcSEcCtD
Alclometasone—Pruritus—Erlotinib—lung cancer	0.000874	0.00967	CcSEcCtD
Alclometasone—Infection—Gemcitabine—lung cancer	0.000852	0.00943	CcSEcCtD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000832	0.00798	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—lung cancer	0.000829	0.00796	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—APP—lung cancer	0.000819	0.00786	CbGpPWpGaD
Alclometasone—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000819	0.00786	CbGpPWpGaD
Alclometasone—Infection—Cisplatin—lung cancer	0.000794	0.00879	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.000789	0.00757	CbGpPWpGaD
Alclometasone—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000787	0.00755	CbGpPWpGaD
Alclometasone—Rash—Topotecan—lung cancer	0.000787	0.00871	CcSEcCtD
Alclometasone—Dermatitis—Topotecan—lung cancer	0.000786	0.0087	CcSEcCtD
Alclometasone—Rash—Erlotinib—lung cancer	0.000779	0.00862	CcSEcCtD
Alclometasone—Dermatitis—Erlotinib—lung cancer	0.000778	0.00861	CcSEcCtD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IRF1—lung cancer	0.000774	0.00743	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000769	0.00738	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—JUNB—lung cancer	0.000758	0.00727	CbGpPWpGaD
Alclometasone—Pruritus—Vinorelbine—lung cancer	0.000755	0.00836	CcSEcCtD
Alclometasone—NR3C1—Circadian Clock—AVP—lung cancer	0.000755	0.00724	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000749	0.00719	CbGpPWpGaD
Alclometasone—Erythema—Docetaxel—lung cancer	0.000746	0.00826	CcSEcCtD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000733	0.00704	CbGpPWpGaD
Alclometasone—Infection—Etoposide—lung cancer	0.000728	0.00805	CcSEcCtD
Alclometasone—Hydrocortisone—ABCG2—lung cancer	0.000717	0.0535	CrCbGaD
Alclometasone—Infection—Paclitaxel—lung cancer	0.000713	0.0079	CcSEcCtD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000699	0.0067	CbGpPWpGaD
Alclometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—lung cancer	0.000698	0.00669	CbGpPWpGaD
Alclometasone—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000696	0.00668	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.00069	0.00662	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.00069	0.00662	CbGpPWpGaD
Alclometasone—Rash—Vinorelbine—lung cancer	0.000673	0.00745	CcSEcCtD
Alclometasone—Dermatitis—Vinorelbine—lung cancer	0.000673	0.00744	CcSEcCtD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—lung cancer	0.000671	0.00644	CbGpPWpGaD
Alclometasone—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000669	0.00642	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—AHR—lung cancer	0.00066	0.00634	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000639	0.00613	CbGpPWpGaD
Alclometasone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000619	0.00594	CbGpPWpGaD
Alclometasone—Pruritus—Gemcitabine—lung cancer	0.000607	0.00672	CcSEcCtD
Alclometasone—Infection—Docetaxel—lung cancer	0.000605	0.00669	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000598	0.00574	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—HIF1A—lung cancer	0.000598	0.00574	CbGpPWpGaD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000598	0.00574	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP2A6—lung cancer	0.000597	0.0446	CrCbGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.000591	0.00567	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000585	0.00562	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.000585	0.00561	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000578	0.00554	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000574	0.00551	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000562	0.00539	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000556	0.00534	CbGpPWpGaD
Alclometasone—Rash—Irinotecan—lung cancer	0.000555	0.00615	CcSEcCtD
Alclometasone—Dermatitis—Irinotecan—lung cancer	0.000555	0.00614	CcSEcCtD
Alclometasone—Methylprednisolone—ABCB1—lung cancer	0.000554	0.0413	CrCbGaD
Alclometasone—Triamcinolone—PTGS2—lung cancer	0.000549	0.041	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—LMNA—lung cancer	0.000547	0.00525	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.000547	0.00524	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000544	0.00522	CbGpPWpGaD
Alclometasone—Rash—Gemcitabine—lung cancer	0.000541	0.00599	CcSEcCtD
Alclometasone—Dermatitis—Gemcitabine—lung cancer	0.00054	0.00598	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000539	0.00517	CbGpPWpGaD
Alclometasone—Erythema—Methotrexate—lung cancer	0.000538	0.00595	CcSEcCtD
Alclometasone—Dexamethasone—ABCG2—lung cancer	0.000534	0.0399	CrCbGaD
Alclometasone—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000521	0.005	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.000521	0.005	CbGpPWpGaD
Alclometasone—Pruritus—Etoposide—lung cancer	0.000518	0.00574	CcSEcCtD
Alclometasone—Pruritus—Paclitaxel—lung cancer	0.000508	0.00562	CcSEcCtD
Alclometasone—Rash—Cisplatin—lung cancer	0.000504	0.00558	CcSEcCtD
Alclometasone—Dermatitis—Cisplatin—lung cancer	0.000504	0.00557	CcSEcCtD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.000503	0.00483	CbGpPWpGaD
Alclometasone—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.0005	0.0048	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.000497	0.00477	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.000493	0.00473	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—CREBBP—lung cancer	0.000489	0.00469	CbGpPWpGaD
Alclometasone—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000481	0.00461	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000474	0.00455	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.000473	0.00454	CbGpPWpGaD
Alclometasone—Erythema—Doxorubicin—lung cancer	0.000466	0.00515	CcSEcCtD
Alclometasone—Rash—Etoposide—lung cancer	0.000462	0.00511	CcSEcCtD
Alclometasone—Dermatitis—Etoposide—lung cancer	0.000461	0.00511	CcSEcCtD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.000457	0.00438	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000455	0.00437	CbGpPWpGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.000454	0.00435	CbGpPWpGaD
Alclometasone—Rash—Paclitaxel—lung cancer	0.000453	0.00501	CcSEcCtD
Alclometasone—Dermatitis—Paclitaxel—lung cancer	0.000452	0.00501	CcSEcCtD
Alclometasone—Betamethasone—PTGS2—lung cancer	0.00045	0.0336	CrCbGaD
Alclometasone—NR3C1—Endoderm Differentiation—APC—lung cancer	0.000445	0.00427	CbGpPWpGaD
Alclometasone—Prednisone—ALB—lung cancer	0.000444	0.0331	CrCbGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.000438	0.00421	CbGpPWpGaD
Alclometasone—Infection—Methotrexate—lung cancer	0.000436	0.00482	CcSEcCtD
Alclometasone—Pruritus—Docetaxel—lung cancer	0.000431	0.00477	CcSEcCtD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.000427	0.0041	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP2E1—lung cancer	0.000424	0.0317	CrCbGaD
Alclometasone—Prednisone—ABCB1—lung cancer	0.000423	0.0316	CrCbGaD
Alclometasone—Dexamethasone—CYP1A1—lung cancer	0.000418	0.0312	CrCbGaD
Alclometasone—Prednisolone—ABCB1—lung cancer	0.00039	0.0291	CrCbGaD
Alclometasone—Rash—Docetaxel—lung cancer	0.000384	0.00425	CcSEcCtD
Alclometasone—Dermatitis—Docetaxel—lung cancer	0.000383	0.00424	CcSEcCtD
Alclometasone—Betamethasone—ABCB1—lung cancer	0.000382	0.0285	CrCbGaD
Alclometasone—Infection—Doxorubicin—lung cancer	0.000377	0.00418	CcSEcCtD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000373	0.00358	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.000372	0.00356	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.000364	0.0035	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.000358	0.00344	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000358	0.00343	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000355	0.00341	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000355	0.00341	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000353	0.00338	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.000343	0.00329	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.00034	0.00326	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000335	0.00322	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.000333	0.0032	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—EP300—lung cancer	0.000333	0.00319	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000328	0.00314	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.00032	0.00307	CbGpPWpGaD
Alclometasone—Pruritus—Methotrexate—lung cancer	0.00031	0.00344	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.00031	0.00297	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000308	0.00296	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000306	0.00293	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000301	0.00289	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—HIF1A—lung cancer	0.000301	0.00288	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.0003	0.00288	CbGpPWpGaD
Alclometasone—Hydrocortisone—ABCB1—lung cancer	0.000298	0.0223	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000298	0.00286	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000297	0.00285	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000289	0.00278	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000289	0.00277	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000288	0.00276	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000287	0.00275	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000285	0.00274	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.000282	0.0027	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000279	0.00267	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000279	0.00267	CbGpPWpGaD
Alclometasone—Rash—Methotrexate—lung cancer	0.000277	0.00306	CcSEcCtD
Alclometasone—Dermatitis—Methotrexate—lung cancer	0.000276	0.00306	CcSEcCtD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000276	0.00264	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000275	0.00264	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000274	0.00263	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000269	0.00258	CbGpPWpGaD
Alclometasone—Pruritus—Doxorubicin—lung cancer	0.000269	0.00298	CcSEcCtD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000265	0.00254	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000262	0.00251	CbGpPWpGaD
Alclometasone—Dexamethasone—PTGS2—lung cancer	0.000262	0.0195	CrCbGaD
Alclometasone—NR3C1—Gene Expression—EIF2B4—lung cancer	0.00026	0.00249	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00026	0.00249	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000257	0.00246	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000257	0.00246	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000254	0.00244	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000252	0.00242	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000249	0.00239	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—RB1—lung cancer	0.000245	0.00235	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000244	0.00234	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000242	0.00232	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000241	0.00231	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.00024	0.00231	CbGpPWpGaD
Alclometasone—Rash—Doxorubicin—lung cancer	0.00024	0.00265	CcSEcCtD
Alclometasone—Dermatitis—Doxorubicin—lung cancer	0.000239	0.00265	CcSEcCtD
Alclometasone—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000239	0.00229	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000235	0.00225	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000234	0.00225	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000232	0.00222	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000225	0.00216	CbGpPWpGaD
Alclometasone—Dexamethasone—ABCB1—lung cancer	0.000222	0.0166	CrCbGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000222	0.00213	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000217	0.00208	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000213	0.00204	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000212	0.00204	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000212	0.00204	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—KHSRP—lung cancer	0.000212	0.00203	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000208	0.00199	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000205	0.00197	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000205	0.00197	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000203	0.00194	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.0002	0.00192	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000196	0.00188	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000193	0.00185	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000185	0.00178	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000182	0.00175	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.00018	0.00172	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.00018	0.00172	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000178	0.00171	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000177	0.0017	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000176	0.00169	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.000173	0.00166	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000169	0.00162	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000168	0.00162	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000168	0.00162	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—DICER1—lung cancer	0.000167	0.00161	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000161	0.00155	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000158	0.00152	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000158	0.00152	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—STAT3—lung cancer	0.000157	0.0015	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000157	0.0015	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000155	0.00149	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.000153	0.00147	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000148	0.00142	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000148	0.00142	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.000146	0.0014	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GCLC—lung cancer	0.000146	0.0014	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000146	0.0014	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SKI—lung cancer	0.000145	0.00139	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000144	0.00139	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000137	0.00131	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000126	0.0012	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2E1—lung cancer	0.000124	0.00119	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	0.000123	0.00118	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—RARB—lung cancer	0.000116	0.00111	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NPPA—lung cancer	0.000113	0.00109	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IL6—lung cancer	0.00011	0.00105	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTP1—lung cancer	0.000103	0.000985	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	0.000101	0.000971	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HSPB1—lung cancer	9.73e-05	0.000933	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	9.46e-05	0.000908	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTM1—lung cancer	9.43e-05	0.000905	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	9.3e-05	0.000893	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	8.96e-05	0.00086	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP1A1—lung cancer	8.94e-05	0.000858	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	8.82e-05	0.000846	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NOTCH3—lung cancer	8.57e-05	0.000823	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—JUNB—lung cancer	8.12e-05	0.000779	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—COL4A3BP—lung cancer	7.87e-05	0.000755	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AZIN2—lung cancer	7.87e-05	0.000755	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ATP5H—lung cancer	6.69e-05	0.000642	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—POMC—lung cancer	6.67e-05	0.00064	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PLBD1—lung cancer	5.96e-05	0.000572	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—ERCC2—lung cancer	5.89e-05	0.000565	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD17B10—lung cancer	5.45e-05	0.000523	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	5.32e-05	0.00051	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CKB—lung cancer	5.07e-05	0.000486	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CNDP2—lung cancer	4.77e-05	0.000457	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTM2—lung cancer	4.77e-05	0.000457	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTMR3—lung cancer	4.64e-05	0.000445	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PGAM1—lung cancer	4.52e-05	0.000434	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CREBBP—lung cancer	4.32e-05	0.000414	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2A7—lung cancer	4.31e-05	0.000414	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SDC4—lung cancer	4.22e-05	0.000405	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA3—lung cancer	3.84e-05	0.000369	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—RRM1—lung cancer	3.84e-05	0.000369	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—B4GALT5—lung cancer	3.61e-05	0.000347	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA4—lung cancer	3.51e-05	0.000337	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA2—lung cancer	3.42e-05	0.000329	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA1—lung cancer	3.3e-05	0.000317	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCC3—lung cancer	3.27e-05	0.000313	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AKR1C1—lung cancer	3.16e-05	0.000304	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UGT1A1—lung cancer	3.07e-05	0.000295	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GNG11—lung cancer	2.96e-05	0.000284	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALDOA—lung cancer	2.82e-05	0.000271	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOA3—lung cancer	2.74e-05	0.000263	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ADCY1—lung cancer	2.66e-05	0.000255	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCG2—lung cancer	2.66e-05	0.000255	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MAPK3—lung cancer	2.63e-05	0.000253	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ENO2—lung cancer	2.61e-05	0.000251	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HPGDS—lung cancer	2.61e-05	0.000251	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.59e-05	0.000249	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MYC—lung cancer	2.56e-05	0.000246	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTT1—lung cancer	2.53e-05	0.000243	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2A6—lung cancer	2.5e-05	0.00024	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GCLC—lung cancer	2.5e-05	0.00024	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ENO1—lung cancer	2.37e-05	0.000228	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2E1—lung cancer	2.13e-05	0.000204	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NQO1—lung cancer	2.1e-05	0.000202	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—STK11—lung cancer	1.9e-05	0.000182	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AKT1—lung cancer	1.78e-05	0.00017	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTP1—lung cancer	1.76e-05	0.000168	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CAT—lung cancer	1.71e-05	0.000164	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCB1—lung cancer	1.66e-05	0.000159	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TYMS—lung cancer	1.63e-05	0.000157	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTM1—lung cancer	1.61e-05	0.000155	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP1A1—lung cancer	1.53e-05	0.000147	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ERCC2—lung cancer	1.52e-05	0.000146	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—APOA1—lung cancer	1.31e-05	0.000126	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CG—lung cancer	1.2e-05	0.000115	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—POMC—lung cancer	1.14e-05	0.000109	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CREBBP—lung cancer	1.11e-05	0.000107	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CD—lung cancer	1.05e-05	0.000101	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALB—lung cancer	1.04e-05	9.97e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CB—lung cancer	9.18e-06	8.81e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTGS2—lung cancer	9.09e-06	8.73e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTEN—lung cancer	7.93e-06	7.61e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—EP300—lung cancer	7.56e-06	7.26e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CA—lung cancer	5.6e-06	5.37e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AKT1—lung cancer	4.57e-06	4.39e-05	CbGpPWpGaD
